- Home
- BBIO vs SWK Comparison
BBIO vs SWK Comparison
Compare BBIO & SWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- SWK
- Stock Information
- Founded
- BBIO 2015
- SWK 1843
- Country
- BBIO United States
- SWK United States
- Employees
- BBIO N/A
- SWK N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- SWK Industrial Machinery/Components
- Sector
- BBIO Health Care
- SWK Consumer Discretionary
- Exchange
- BBIO Nasdaq
- SWK Nasdaq
- Market Cap
- BBIO 9.4B
- SWK 11.1B
- IPO Year
- BBIO 2019
- SWK N/A
- Fundamental
- Price
- BBIO $53.33
- SWK $79.38
- Analyst Decision
- BBIO Strong Buy
- SWK Buy
- Analyst Count
- BBIO 16
- SWK 10
- Target Price
- BBIO $64.44
- SWK $93.33
- AVG Volume (30 Days)
- BBIO 2.1M
- SWK 2.2M
- Earning Date
- BBIO 11-11-2025
- SWK 10-28-2025
- Dividend Yield
- BBIO N/A
- SWK 4.25%
- EPS Growth
- BBIO N/A
- SWK N/A
- EPS
- BBIO N/A
- SWK 3.16
- Revenue
- BBIO $235,812,000.00
- SWK $15,161,600,000.00
- Revenue This Year
- BBIO $115.97
- SWK $0.40
- Revenue Next Year
- BBIO $65.50
- SWK $4.01
- P/E Ratio
- BBIO N/A
- SWK $24.75
- Revenue Growth
- BBIO 7.62
- SWK N/A
- 52 Week Low
- BBIO $21.72
- SWK $53.91
- 52 Week High
- BBIO $54.60
- SWK $110.88
- Technical
- Relative Strength Index (RSI)
- BBIO 60.01
- SWK 60.27
- Support Level
- BBIO $49.94
- SWK $76.06
- Resistance Level
- BBIO $54.29
- SWK $81.44
- Average True Range (ATR)
- BBIO 2.06
- SWK 2.18
- MACD
- BBIO -0.18
- SWK 0.11
- Stochastic Oscillator
- BBIO 73.81
- SWK 79.68
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About SWK Stanley Black & Decker Inc.
Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates in two reportable segments namely Tools and Outdoor and Industrial. It generates maximum revenue from the Tools and Outdoor segment. The Tools and Outdoor segment is comprised of the Power Tools Group (PTG), Hand Tools, Accessories and Storage (HTAS), and Outdoor Power Equipment (Outdoor) businesses. Geographically, the company generates revenue from the United States, Canada, Other Americas, Europe, and Asia. It derives a majority of its revenue from the United States.